HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Options Trader
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
Growth Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

MRGE: Merge Healthcare Inc - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

MERGE HEALTHCARE INC (NASD)
MRGE 2.07 -0.11 (-5.05%) Vol.  717,696 15:59 ET

Day Low - High 2.02 - 2.20
52wk Low - High 1.25 - 4.78
Avg Volume 371,396
Industry MEDICAL INFO SYSTEMS
Market Cap 163.96 M
Div - Yield 0.00 - 0.00
PE (forward) 9.08
PEG Ratio .52
Current Year Est. .24
EPS Last Year 0.09
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Strong Buy28.07%
# 2Buy18.96%
# 3Hold10%
# 4Sell4.11%
# 5Strong Sell1.76%
S&P5009.45%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


downgraded 02/17/2010
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 02/18/2010
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
MERGE HEALTHCARE INC MRGE PREMIUM
ATHENAHEALTH IN ATHN PREMIUM
CERNER CORP CERN PREMIUM
ECLIPSYS CORP ECLP PREMIUM
See all MEDICAL INFO SYSTEMS Peers

BROKERAGE RECOMMENDATIONS
Current ABR 3.00
ABR (Last Week) 3.00
# of Recs in ABR 3
Average Target Price 3.10
Industry Rank by ABR 146 out of 264
Rank in Industry 18 out of 18
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate MRGE?
Buy
Sell
Find out what the Zacks Community
thinks of MRGE at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR MRGE
Zacks Blog: Zacks Analyst Blog Highlights: Allscripts-Misys Healthcare Solutions, Inc., Cerner Corp., Merge Healthcare Inc., Quality Systems Inc. and MedAssets Inc.
Mar 11, 2010
Zacks Blog: New Client for Allscripts
Mar 10, 2010
Zacks Blog: Merge Set to Acquire AMICAS
Mar 08, 2010
Zacks Blog: New Clients for Allscripts
Mar 05, 2010
Zacks Blog: Merge Launches New Device
Mar 05, 2010
Zacks Blog: Merge Arranges Funds
Feb 25, 2010
Zacks Blog: Allscripts Remains at Neutral
Feb 24, 2010
Zacks Blog: Merge Remains at Underperform
Feb 18, 2010
More Zacks Commentary
NEWS
Merge Healthcare Downward Momentum Looks to Continue (MRGE)
Mar 11, 2010
Zacks Analyst Blog Highlights: Allscripts-Misys Healthcare Solutions, Inc., Cerner Corp., Merge Healthcare Inc., Quality Systems Inc. and MedAssets Inc.
Mar 11, 2010
Merge Healthcare Set to Acquire Amicas for $248 Million (MRGE,AMCS)
Mar 09, 2010
Amicas Agrees To $248 Million Merge Healthcare Buyout
Mar 08, 2010
AMICAS Agrees To Be Acquired By Merge Healthcare For $6.05 Per Share In Cash
Mar 05, 2010
Merge Healthcare: The Trend Continues Lower (MRGE)
Mar 04, 2010
Merge Healthcare and Massachusetts General Hospital Start Pilot Project
Mar 02, 2010
Merge Healthcare Launches eFilm Mobile(TM)
Mar 02, 2010
More News
EARNINGS ESTIMATES
  This Quarter
03/2010
Next Quarter
06/2010
This Year
12/2010
Next Year
12/2011
Average Estimate 0.03 0.05 0.24 0.28
Number of Estimates 1 1 1 1
Low Estimates 0.03 0.05 0.24 0.28
High Estimate 0.03 0.05 0.24 0.28
Year Ago EPS 0.05 0.01 0.16 0.24
EPS Growth -40.00% 400.00% 50.00% 16.67%

More Estimates

COMPANY DESCRIPTION
MERGE HEALTHCARE is a developer of medical imaging and clinical software applications and developmental tools that are on the forefront of medicine. The Company develops medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Their software technologies accelerate market delivery for their OEM customers, while their end-user solutions improve their customers' productivity and enhance the quality of the patient experience.

Full Company Report
FINANCIALS
EPS TTM .09
Sales 66.84
Net Income .28
Price/Earnings 24.22
Price/Book 2.41
Price/Cash Flow 13.06
Price/Sales 2.45


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2010 Zacks Investment Research